Hyperliquid Strategies Inc (NASDAQ:PURR – Get Free Report) shares gapped up prior to trading on Monday . The stock had previously closed at $10.58, but opened at $10.97. Hyperliquid Strategies shares last traded at $11.3690, with a volume of 8,207,981 shares trading hands.
Analysts Set New Price Targets
Several research analysts have recently weighed in on the company. Cantor Fitzgerald increased their price target on Hyperliquid Strategies from $8.00 to $18.40 and gave the stock an “overweight” rating in a research note on Wednesday, July 1st. Chardan Capital reiterated a “buy” rating and set a $9.75 target price on shares of Hyperliquid Strategies in a research report on Friday, June 12th. Finally, Weiss Ratings raised shares of Hyperliquid Strategies from a “sell (d)” rating to a “sell (d+)” rating in a research report on Wednesday, June 3rd. Three research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $12.72.
Read Our Latest Research Report on Hyperliquid Strategies
Hyperliquid Strategies Stock Performance
Institutional Investors Weigh In On Hyperliquid Strategies
A number of institutional investors and hedge funds have recently made changes to their positions in PURR. BlackRock Inc. bought a new stake in Hyperliquid Strategies during the second quarter valued at $79,842,000. Paradigm Operations LP purchased a new stake in shares of Hyperliquid Strategies in the 4th quarter valued at about $20,327,000. Galaxy Group Investments LLC purchased a new position in shares of Hyperliquid Strategies during the fourth quarter worth about $15,167,000. Pantera Capital Partners LP bought a new position in shares of Hyperliquid Strategies in the fourth quarter worth approximately $14,545,000. Finally, Feynman Point Asset Management LLC purchased a new stake in Hyperliquid Strategies in the fourth quarter valued at approximately $14,431,000. Hedge funds and other institutional investors own 9.45% of the company’s stock.
About Hyperliquid Strategies
Hyperliquid Strategies Inc is a digital asset treasury company whose primary focus is to maximize shareholder value through accumulating HYPE, the native token of Hyperliquid, a high-performance blockchain custom-built to house all of finance. Hyperliquid Strategies Inc, formerly known as Sonnet BioTherapeutics Holdings Inc, is based in NEW YORK.
Recommended Stories
- Five stocks we like better than Hyperliquid Strategies
- MongoDB Is Surging—And the Next Catalyst Is Almost Here
- If Boeing Ramps Up Production, These Suppliers May Win Big
- Marvell Takes a Shot a Broadcom’s Throne With Google Deal
- 5 of the Most-Upgraded Stocks Over the Last Quarter Are All Software Names—Here’s Why
Receive News & Ratings for Hyperliquid Strategies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hyperliquid Strategies and related companies with MarketBeat.com's FREE daily email newsletter.
